close-icon

MHQ: Clinical IntelligencePowered by SurvivorNet

  • health-panel

    Health Panel

  • clinical-trial

    Clinical Trials

    ?
Prefer to talk instead of typing?
close-icon

Answers offered are informational and do not constitute medical advice. Learn more

close-icon
Health Profile

Enter health info to personalize results.

What is your gender?

What is your age?

close-icon
Clinical Trials

clinical-icon

filter

Clear List

Ask me anything about your health...

I’m listening

thinking

responding

close-icon close-icon
close-icon
close-icon
close-icon
left-icon Back to Results

Dr. Rajshekhar Chakraborty

location-icon

New York, NY

LOCATION OF PRACTICE
New York Presbyterian/columbia University Medical Center
MEDICAL Specialty:

Amyloidosis, Hereditary Amyloidosis, Osteosarcoma



161 FORT WASHINGTON AVE, NEW YORK, NY, 100323729
630 W 168TH ST # 4, NEW YORK, NY, 100323725
212-305-5098
NPI Number
1760728893
ABOUT

Rajshekhar Chakraborty, MD, is a Medical Oncologist in New York, NY. He has 11 years of experience and is board certified in Hematology, frequently treating conditions like Amyloidosis and Osteosarcoma. Chakraborty graduated from the University of Delhi and is affiliated with NewYork-Presbyterian/Columbia University Medical Center.

Dr. Rajshekhar Chakraborty profile image

Published Articles

Antibacterial activity of novel nanoparticles against persistent endodontic pathogens.- 2025
Socio-political indicators of food insecurity: a study of 24 US states.- 2026 Mar 26
Comparative analysis of placental transmission mechanisms for Dengue and Zika viruses: outcomes and future directions.- 2026
Towards identification of novel inhibitors of EGFR mutants through in-silico approach.- 2026 Mar 16
S1P-S1PR1 signaling impairs CD8(+) T cell metabolism and effector function in tumors.- 2026 Mar 19
Impaired α-Synuclein aggregate clearance in neuronal cells drive their spread to microglia through tunneling nanotubes.- 2026 Mar 12
Investigation of Plant Growth Promotion Potential of Novel Compost-Derived Bacilli and Anticipating Their In Vivo Effectiveness Through Mathematical Modelling.- 2026 Apr
Predicting Early Mortality in Newly Diagnosed AL Amyloidosis: Development and Validation of the PACE Score for Daratumumab-Treated Patients.- 2026 Apr
Incidence, Progression and Determinants of Diabetic Retinopathy in Type 2 Diabetes in Australasia: A Systematic Review and Meta-Analysis.- 2026 Mar 5
Uncovering contextual risk patterns in cannabis-involved fatal crashes: A data-driven approach to public health-oriented road safety.- 2026 Feb

Clinical Trials

Venetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) Amyloidosis
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Teclistamab-Daratumumab in AL Amyloidosis
Non-invasive MRD Assessment in Multiple Myeloma

Other Specialists treating Amyloidosis, Hereditary Amyloidosis, Osteosarcoma in New York, NY

See All Doctors

Dr. Uroosa Ibrahim

Specialty: Osteosarcoma, Multiple Myeloma, Pancytopenia

My Resources
location-icon

Mount Sinai Hospital

My Resources

Dr. Melinda Merchant

Specialty: Bone Cancer, Osteosarcoma, Secondary Malignancies

My Resources
My Resources

Dr. Andrea Popescu-Martinez

Specialty: Osteosarcoma, Anemia, Colorectal Cancer

My Resources
location-icon

NYC Health + Hospitals/Bellevue

My Resources

Dr. Lauren McVoy

Specialty: Anemia, Coagulation Disorders, Osteosarcoma

My Resources
location-icon

Memorial Sloan Kettering Cancer Center

My Resources

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider